Hiroyuki Araki

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Shinji Kuroda · 2 shared papers, 2020–2022 · strength 0.23
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
2. Yuzo Umeda · 2 shared papers, 2020–2022 · strength 0.23
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
3. Ryuichi Yoshida · 2 shared papers, 2020–2022 · strength 0.23
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
4. Toshiyoshi Fujiwara · 2 shared papers, 2020–2022 · strength 0.23
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
5. Yoshinori Kajiwara · 1 shared paper, 2022 · strength 0.14
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
6. Masashi Hashimoto · 1 shared paper, 2022 · strength 0.14
   • Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
7. Takeshi Koujima · 1 shared paper, 2020 · strength 0.10
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
8. Ryohei Shoji · 1 shared paper, 2020 · strength 0.10
   • Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
9. Motoki Ninomiya · 1 shared paper, 2015 · strength 0.04
   • Paper [Efficacy of Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Involving the Superior Mesenteric Artery]. PMID 26805071↗
10. Hiroyoshi Matsukawa · 1 shared paper, 2015 · strength 0.04
    • Paper [Efficacy of Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Involving the Superior Mesenteric Artery]. PMID 26805071↗
11. Kazuhiro Yoshida · 1 shared paper, 2015 · strength 0.04
    • Paper [Efficacy of Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Involving the Superior Mesenteric Artery]. PMID 26805071↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.